VERA
Vera Therapeutics Inc
30.30$
+2.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +42.9% | +18.0% | -45.8% | -71.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.2% | -299.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +49.9% | – | – | – | – | – | – | – | -122.7% | – | – | |
| – | +35.8% | +0.8% | +1,923.6% | -92.6% | +10.3% | +10.2% | +257.8% | -1.6% | -19.4% | +94.4% | +35.7% | -4.0% | -36.6% | -0.8% | +36.3% | +12.4% | +18.8% | +37.5% | -17.3% | +23.8% | +40.7% | -2.8% | +5.5% | +44.4% | -30.1% | – | |
| – | +18.1% | -46.5% | +74.2% | +57.0% | +46.5% | +41.1% | +3.9% | +16.7% | +10.6% | +13.0% | +23.6% | -10.9% | -6.7% | -1.4% | +10.4% | +26.7% | +1.5% | +18.1% | +64.1% | -6.3% | +50.5% | -0.9% | +60.4% | +12.1% | +34.0% | – | |
| – | +28.4% | +27.2% | +954.2% | -88.9% | +24.0% | +24.0% | +128.7% | +2.6% | -11.5% | +67.7% | +33.0% | -5.4% | -30.8% | -1.0% | +27.2% | +15.9% | +16.5% | +33.4% | -1.8% | +16.9% | +39.1% | +5.5% | +13.6% | +31.3% | -10.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +162.5% | +1.6% | -76.6% | -86.7% | +120,500.0% | -85.1% | -94.4% | +490.0% | +8.5% | +14.8% | +307.5% | +45.9% | +4.6% | +3.2% | +12.0% | +80.5% | +0.3% | +1.3% | -3.4% | -4.2% | +4.6% | +4.6% | +187.0% | -67.6% | +1.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +14,266.7% | -1.9% | -99.8% | -300.0% | – | – | -99.7% | +6,300.0% | +773.4% | -201.1% | – | -31,600.0% | – | -39.8% | -99.9% | -99,627.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.